Ryuji Kubota
- Co-authors
- Junichi AzumaMasako OhnoTakayuki NagaiKazunari TsuyuguchiYasushi FujioTetsuya TakashimaIchiro KawaseYasuhisa Okuda
- Topics
- SARS-CoV-2 and COVID-19 Research (6 papers)Pharmacogenetics and Drug Metabolism (6 papers)COVID-19 Clinical Research Studies (5 papers)
- Cited by
- PharmacologyInfectious Diseases
In The Last Decade
Ryuji Kubota
19 papers receiving 365 citations
Peers
Comparison fields: 5 of 73
- Infectious Diseases 184
- Pharmacology 129
- Molecular Biology 81
- Epidemiology 80
- Pharmacology 77
Countries citing papers authored by Ryuji Kubota
This map shows the geographic impact of Ryuji Kubota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuji Kubota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuji Kubota more than expected).
Fields of papers citing papers by Ryuji Kubota
This network shows the impact of papers produced by Ryuji Kubota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuji Kubota. The network helps show where Ryuji Kubota may publish in the future.
Co-authorship network of co-authors of Ryuji Kubota
This figure shows the co-authorship network connecting the top 25 collaborators of Ryuji Kubota. A scholar is included among the top collaborators of Ryuji Kubota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuji Kubota. Ryuji Kubota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 13 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 6 | |
| 8 | 19 | |
| 9 | 1 | |
| 10 | 35 | |
| 11 | 9 | |
| 12 | 14 | |
| 13 | 8 | |
| 14 | 2 | |
| 15 | 9 | |
| 16 | 184 | |
| 17 | 12 | |
| 18 | 33 | |
| 19 | 4 | |
| 20 | 13 |
About Ryuji Kubota
Ryuji Kubota is a scholar working on Pharmacology, Modeling and Simulation and Infectious Diseases, having authored 20 papers that have together received 377 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Pharmacology (129 citations), Infectious Diseases (184 citations) and Pharmacology (77 citations). Ryuji Kubota has collaborated with scholars based in Japan and Egypt. Frequent co-authors include Junichi Azuma, Masako Ohno, Takayuki Nagai, Kazunari Tsuyuguchi, Yasushi Fujio, Tetsuya Takashima, Ichiro Kawase, Yasuhisa Okuda, Soichiro Yokota and Ryosuke Shimizu. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Pharmaceutical Research and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.